Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the...

Within the past few years, new treatments have begun to turn the tide against metastatic melanoma, improving and even saving the lives of countless people with this deadly disease.

Approval follows positive CHMP opinion based on pivotal Phase II study showing durable objective response rate per central review of 56% in patients with laBCC1 Basal cell carcinoma is the...

While people with fewer than 50 moles may not be as at risk for melanoma as people with more moles, they may be more at risk for aggressive melanoma, according to new research.

New research from Johns Hopkins finds organ transplant recipients are at increased risk of melanoma skin cancer, with many likely to be diagnosed in the advanced stages.

In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.

Research also yields realistic new model of melanoma for testing therapiesMoles are benign tumors found on the skin of almost every adult.

Scientists are adding new DNA to the cells of patients in a world-first treatment to attack and kill melanoma skin cancers.

Scientists from the University of Leeds have uncovered further evidence that the protective buffers at the ends of chromosomes - known as telomeres - are fundamental to the understanding of the...

NICE has published its first guideline on melanoma which aims to reduce the numbers of people dying from the disease, and addresses the wide variations across the country in diagnosis and treatment.